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A normal prion protein (PrP
c) is converted to a protease-
resistant isoform by an apparent self-propagating activity
in transmissible spongiform encephalopathy, a neuro-
degenerative disease. The cDNA encoding open reading
frame (ORF) of the bovine prion protein gene (Prnp) was
cloned from Korean cattle by PCR, and was transfected
into Chinese hamster ovary (CHO-K1) cells using
lipofectamine. The gene expression of the cloned cDNA was
confirmed by RT-PCR and Western blotting with the
monoclonal antibody, 6H4. Cellular changes in the
transfected CHO-K1 cells were investigated using
parameters such as MTT, lactate dehydrogenase (LDH),
and superoxide dismutase (SOD) activities, as well as nitric
oxide (NO) production, and an apoptosis assay. In the MTT
and LDH assays, the bovine PrnP-transfectant showed a
lower proliferation rate than the wild-type (p < 0.05).
Production of NO, after LPS or ConA stimulation, was not
detected in either transfectants or CHO-K1 cells. In SOD
assay under ConA stimulation, the SOD activity of
transfectants was 10 times higher than that of CHO-K1
cells at 6 h after treatment (p < 0.05). The genomic DNA of
both the transfectants and control cells began to be
fragmented at 6 h after treatment with cyclohexamide.
Caspase-3 activity was reduced by transfection with the
bovine  Prnp ( p< 0.05). Conclusively, the viability of
transfectants expressing exogenous bovine Prnp was
decreased while the capacities for cellular protection
against antioxidative stress and apoptosis were increased.
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Introduction
Bovine spongiform encephalopathy (BSE) is thought to
be among the transmissible spongiform encephalopathies
(TSEs), also referred to as prion diseases, which are fatal
neurodegenerative disorders and share important mechanistic
aspects with other, more frequently occurring diseases such
as Alzheimer’s, Huntington’s, and Parkinson’s disease
[11,26]. The TSEs, including BSE, are characterized by
neuronal vacuolation and accumulation of the abnormal
isoform (PrP
Sc) of a host-encoded cellular membrane
glycoprotein, referred to as normal prion protein (PrP
C), in
the central nerve system [14,38]. BSE, which reached
epidemic proportions in Britain in the 1990s and is
increasing in many other countries as well, has been
transmitted to more than 100 human beings through the
consumption of infected beef [9,11]. Due to the risks to
public health as a causative agent of variant Creutzfeldt-
Jakob disease (vCJD) and its role as an example of a novel
mechanism of biological information transfer based on the
transmission of protein conformation rather than on the
inheritance of a nucleic acid sequence, vCJD has now
become a subject of general interest [1,9,27,36]. In countries
from which the emergence of BSE has not yet been
reported, its risks to cattle and public health still remain, and
an active screening method and means of control for BSE
are strongly needed.
Beginning with research on the pathogenesis of BSE, lots
of efforts have been focused on topics such as the physiological
roles of PrP
C, as well as transmission, diagnosis, therapy,
and prophylaxis. The normal function of PrP
C remains to be
established. However, its localization on the cell surface via
a glycosylphosphatidylinositol (GPI) anchor would be
consistent with roles in cell adhesion and recognition, ligand
uptake, or transmembrane signaling, as well as neuroprotective
function [4,5,7,8,11,25,26]. The conformational conversion
of PrP
C into the abnormal isoform PrP
Sc, as well as depletions,
mutations, or topological aberrations in prion protein gene
(Prnp), may lead to loss-of-function components in prion
disease [9,22,23,30]. Despite its potential risk as a zoonotic
disease, the proteinase K-resistant property of PrP
Sc is the
only pathway for diagnosis. Currently, the main method of
diagnosis of BSE is based on the postmortem detection of
PrP
Sc by means of immunological techniques such as enzyme-
linked immunosorbent assay, Western blot, and immuno-
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histochemistry, together with histopathology [12].
Chinese hamster ovary (CHO-K1) cells have recently
been used to study gene expression, toxicity screening, cell
biology, and virology, as well as prion disease [1,3,6,19,33].
A detailed analysis of the characterization of CHO-K1 cells
transfected with a Prnp has not been performed, in spite of
the fact that it is an essential component of the cellular
biology of prion disease. Moreover, most BSE research has
been deduced from experimental mouse Prnp models, in
vitro and in vivo, since these models are well-understood
and easy to use even though the nucleotide and predicted
amino acid sequence of the bovine Prnp ORF are
approximately 78% and 84% homologous to those of the
mouse, respectively [15].
To better understand and control BSE, a BSE-specific
experimental model is needed. As basic research of BSE
biology, we attempted to constitute the immortalized cell
line stably expressing bovine Prnp with CHO-K1 cells and
investigate the characteristics, which followed the gene
expression using different parameters of cell biology.
Materials and Methods
Cell culture of CHO-K1 cells
The wild-type CHO-K1 cells were purchased from the
Korean Cell Line Bank (KCLB No. 10061) and maintained
in Dulbecco’s modified Eagle’s medium (DMEM; Gibco,
USA) with a high glucose concentration (4.5 g/l) supplemented
with 10% fetal bovine serum and 2 mM glutamine,
penicillin, and streptomycin at 37 in a 5% CO 2 incubator.
Transfection of bovine Prnp 
The cDNA encoding the Prnp ORF of Korean cattle, with
264 amino acids and a predicted molecular weight of 28 kDa
[15], was cloned into the pIRESpuro2 eukaryotic expression
vector (Clontech, USA), and was transfected in the CHO-
K1 cells using lipofectamine (Invitrogen, USA). The CHO-
K1 cells expressing bovine prion protein were constructed
by selection of the puromycin-resistant cells in the complete
medium containing 30 µg/ml puromycin. To obtain one cell
clone, the puromycin-resistant cells were resuspended and
the dilution was calculated to give 2 cells/ml in the complete
medium. The diluted cells were plated into 96-well plates
and incubated for a week at 37 under 5% CO 2.
PCR and RT-PCR
The insertion and expression of the cloned cDNA were
analyzed by genomic PCR and RT-PCR, respectively.
Genomic DNA from each clone was extracted using a
genomic DNA purification kit (Promega, USA), and PCR
was performed to screen the gene transfer with a forward
primer, 5'-GAATTCATGGTGAAAAGCCACATAGGCAG
TTGG-3', and a reverse primer, 5'-GAATTCCTATCCTAC
TATGAGAAAAATGAGGAA-3’. The PCR amplification
consisted of an initial denaturation at 94
oC for 5 min,
followed by 30 cycles of denaturation at 94
oC for 30 sec,
annealing at 60
oC for 30 sec, extension at 72
oC for 1 min 30
sec, and then a final extension at 72
oC for 15 min. PCR
products were analyzed by electrophoresis on 1.0% agarose
gel. Total RNA was isolated from the positive one cell
clones using Trizol reagent (Invitrogen, USA) and chloroform.
Aqueous total RNA was precipitated by the addition of
isopropanol and centrifuged at 12,000 × g for 10 min. The
RNA pellets were washed once with 75% ethanol and
dissolved in diethylpyrocarbonate-treated water. The RNA
was treated with 2 units of RNase-free DNase at 37
oC for
30 min to remove the residual DNA. Single-stranded cDNA
was synthesized using the superscript III preamplification
system for the first-strand cDNA synthesis system (Invitrogen,
USA). Five µg of purified total RNA was incubated with 100
units of superscript III reverse transcriptase at 50
oC for 50 min
in the presence of 10X RT buffer, 25 mM MgCl 2, 0.1 M
DTT, 10 mM dNTP, and 50 µM oligo dT. The synthesized
single-stranded cDNA were treated with 2 units of RNase H
at 37
oC for 20 min to remove RNA, and PCR was then
performed as described above to screen for gene transcription
of bovine Prnp.
Immunoprecipitation
Cells were lysed with cold RIPA buffer (50 mM Tris-HCl,
150 mM NaCl, 1 mM PMSF, 1 mM EDTA, 5 µg/ml aprotinin,
5µg/ml leupeptin, 1% TritonX-100, 1% sodium deoxycholate,
0.1% SDS), and the lysate was precleared by the addition of
control mouse IgG purified using HiTrap protein G HP
(Amersham, Australia), together with protein G agarose
(Santa Cruz, USA). The supernatant was then incubated
with 6H4 monoclonal antibody, which was kindly provided
by Dr. A. Zurbriggen [18]. Incubation was followed by the
addition of protein G-agarose at 4
oC; the mixture was
subjected to soft shaking overnight. The immunoprecipitates
were boiled with electrophoresis sample buffer (50 mM Tris-
Cl, pH 6.8, 100 mM dithiothreitol, 2% SDS, 0.1%
bromophenol blue, 10% glycerol) and loaded for 12% SDS-
PAGE. Proteins were then transferred to nitrocellulose
membranes (BioRad, USA) using a semidry blotting
system. The blots were incubated with the 44B1 monoclonal
antibody [17], and then with alkaline phosphatase-
conjugated anti-mouse IgG. Detection was performed by
visualization using BCIP/NTB substrate (BioRad, USA).
MTT and LDH assay
CHO-K1 cells and bovine Prnp-transfectants were plated
in 96-well microplates at a density of 8 × 10
3 cells/well and
cultured for 72 h at 37
oC under 5% CO2. For the MTT assay,
the culture medium was replaced by 200 µl of fresh
medium, and sterile filtered 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyl tetrazolium bromide (MTT; Sigma, USA) was
added to each well, reaching a final concentration of 1.0 mg/ml.Biological characteristics of CHO-K1 transfected with bovine  Prnp 133
Unreacted dye was removed after 4 h, the insoluble formazan
crystals were dissolved in 200 µl of dimethylsulfoxide
(Sigma, USA), and absorbance was measured at a
wavelength of 570 nm. The relative cell proliferation (%)
was related to a 100% confluence per well in the A 570 test/
A570 100% confluence well [24]. For the lactate dehydro-
genase (LDH) assay, the concentration in the culture
medium was measured using the homogeneous membrane
integrity assay (CytoTox-ONE; Promega, USA), allowing
the spectrophotometric determination of the nicotinamide
adenine dinucleotide reduction at 490 nm. Controls were
performed with 1% TritonX-100 and set as 100% LDH
release. The relative LDH release (%) is defined as the ratio
of LDH released to the total LDH in the intact cells.
NO production and SOD activity assay
CHO-K1 cells and bovine Prnp-transfectants were plated
in 60 mm cell culture dishes at a density of 5.0 × 10
5 cells/
dish. These cells were stimulated with 1 µg/ml of lipopoly-
saccharide (BioWhittaker, USA) or 5 µg/ml of concanavalin
A (ConA; Sigma, USA) in serum-free medium (Opti-MEMI;
Invitrogen, USA). The nitric oxide (NO) level from each
culture supernatant was determined by the Griess reaction,
using Griess reagent (1% sulfanilamide and 0.1% N-1-
napthylethylenediamine dihydrochloride in 2.5% phosphoric
acid). The culture media and serially-diluted sodium nitrite
were used as standard references. Absorbances were measured
with a 540 nm filter, and the concentration of NO was
determined by comparison to the standard curve. Superoxide
dismutase (SOD) activity was determined by using the
superoxide dismutase assay kit (Cayman, USA) according
to the protocol of the manufacturer, which utilizes a
tetrazolium salt for the detection of superoxide radicals
generated by xanthine oxidase. The stimulated cells from
each time point were lysed and mixed with the radical
detector, and the catalysis of SOD was then initiated by the
addition of xanthine oxidase. The absorbances were read at
450 nm, and SOD activities of the samples were calculated
using a serially-diluted SOD standard reference curve. SOD
activity (unit/ml) was represented in units. One unit was
defined as the amount of enzyme needed to exhibit 50%
dismutation of the superoxide radical per milliliter.
DNA fragmentation and caspase-3 activity assay 
CHO-K1 and bovine Prnp-transfectant were plated in 60
mm cell culture dishes at a density of 5.0 × 10
5 cells/dish,
and were treated with 200 µg/ml cyclohexamide. For the
DNA fragmentation assay, cells were collected at specific
time points and lysed. Genomic DNA from the cell lysate
was isolated, and the pattern of fragmented DNA was then
analyzed by 1.5% agarose gel electrophoresis. Caspase-3
activity was measured by using assay system (CaspACE;
Promega, USA) according to the protocol of the manufacturer.
The cells from each time point were lysed, and the lysates
were then reacted with the colorimetric substrate (Ac-
DEVD-pNA) provided in the kit. The chromophore p-
nitroaniline (pNA) released by caspase-3 from the cell lysate
was monitored by a spectrophotometer at 405 nm. The
activities of caspase-3 were calculated in comparison to the
pNA calibration curve.
Statistical analysis
Statistical analysis was performed using Excel and SAS
software (SAS, USA). All results are expressed as the
mean ± SD. Differences were analyzed with Student’s  t-test
and considered to be significant if probability values of
p < 0.05 were obtained.
Results
Transfection of bovine Prnp
The pIRESpuro2 eukaryotic expression vector, which
harbored cDNA encoding bovine Prnp ORF with 264
amino acids, was transfected into CHO-K1 cells, and the
bovine Prnp-transfectants were selected by culturing in a
complete medium containing puromycin. No specific
morphological changes of transfected cells were detected by
microscopic comparison with wild-type cells.
After drug selection, a limiting dilution was performed,
and several clones of bovine Prnp-transfectant were obtained.
Genomic DNA was analyzed by PCR in order to screen for
the harboring of the transfected genes in each cell clone, and
RT-PCR was then carried out to screen for gene transcription
against the positive clones in the PCR analysis. The
amplicons that were 795 bp in size, a size that is identical to
that of full-length bovine Prnp ORF, were amplified by both
PCR and RT-PCR; however, no specific band was observed
in the lane of the CHO-K1 cells control (Fig. 1). Two clonal
lines that expressed stable levels of bovine PrP
C were
obtained by screening gene transfer and transcription.
The expression of exogenous bovine prion protein was
confirmed by Western blot analysis. Before Western blotting,
prion proteins in transfected cells were immunoprecipitated
by a combination of protein G-agarose beads and 6H4
monoclonal antibodies, which encompass amino acid
residues 144 to 152. Two major bands with a molecular
weight of about 31 kDa were detected (Fig. 1).
Biological characteristics of bovine Prnp-transfectant
Cell proliferation and viability rates of wild-type CHO-K1
cells and bovine Prnp-transfectants were measured by the
MTT test and LDH assay. In the MTT test, wild-type cells
showed a higher rate of proliferation (91.3 ± 2.4%) than the
transfectant (68.7 ± 6.7%) (p < 0.05). In the LDH assay for
cell viability, the relative LDH release of wild-type cells
(2.7 ± 0.3%) was less than that of the transfectant (6.3 ± 0.9%)
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NO and SOD Assay
In the NO assay, no detectable amount of nitrite was
measured in the culture supernatant following stimulation
with either LPS or ConA. The SOD activity in bovine Prnp-
transfectant (5.2 units) was increased as compared with the
wild-type (0.5 units) 6 h after ConA stimulation (p < 0.05).
However, no significant difference was observed after
treatment with LPS (Fig. 3).
DNA fragmentation and caspase-3 activity assay
To estimate the resistance against apoptosis, DNA
fragmentation and caspase-3 activity assays were performed.
At 6 h after cyclohexamide treatment, fragmented DNAs
became evident; however, it was difficult to distinguish any
visual differences between the bovine Prnp-transfectant and
the wild-type. The caspase-3 activity in the transfectant was
lower (14.0 ± 0.2 pmol) than in the wild-type (16.3 ± 0.6 pmol)
at 24 h after cyclohexamide treatment (p < 0.05) (Fig. 4).
Fig. 1. Analysis of CHO-K1 cells transfected with bovine  Prnp
(boPrP). Panels A and B are agarose gel (1.0%) electrophoresis
patterns of genomic PCR and RT-PCR, respectively. Lane L:
100 bp DNA ladder; Lane 1: cloned vector used for transfection;
Lane 2: wild-type CHO-K1 cells as a control; Lanes 3 and 4:
CHO-K1 cells transfected with bovine Prnp, one cell clone no.
20 and 25, respectively. Panel C shows the result of a Wester n
blot to confirm the expression of bovine prion protein. Prior to
the Western blot, prion protein was immunoprecipitated by
combination of mAb, 6H4, and protein G-coupled agarose beads.
Lane 1: wild-type CHO-K1 cells as a control; Lanes 2 and 3:
CHO-K1 cells transfected with bovine Prnp, one cell clone no.
20 and 25, respectively.
Fig. 2. Proliferation and viability analysis of wild-type CHO-K1 cells (CHO) and CHO-K1 cells transfected with bovine  Prnp (PrP)
using MTT and LDH assays, respectively. The relative cell proliferation (%) is related to 100% confluence per well in the A 570 test/A570
100% confluence well. The relative LDH release (%) is defined by the ratio of LDH released to the total LDH in the intact cells .
Asterisk (*) indicates a significant difference ( p < 0.05).
Fig. 3. Analysis of SOD activity in wild-type CHO-K1 (CHO)
and CHO-K1 cells transfected with bovine Prnp (PrP). Both
types of cells were treated with 1 µg/ml of LPS or 5 µg/ml
ConA. One unit is defined as the amount of enzyme needed to
exhibit 50% dismutation of the superoxide radical. *p <0 . 0 5
compared with wild-type CHO-K1 cells treated with ConA.Biological characteristics of CHO-K1 transfected with bovine  Prnp 135
Discussion
These experiments were carried out as basic research for
understanding BSE biology through the establishment of an
in vitro cellular model. We constituted bovine Prnp-
transfectant with the CHO-K1 cell line and examined
cellular changes followed by expression of the bovine prion
protein. The CHO-K1 cells were transfected with an
expression vector containing bovine Prnp ORF, and the
transfected cells were selected in a complete medium
containing puromycine. The selected cells were then limit-
diluted and plated to prepare one cell clone. The primer set
used in genomic PCR and RT-PCR was specific for the
bovine  Prnp introduced into the CHO-K1 cell line, so it
could not bind to endogenous hamster Prnp, although the
homology of these ORF nucleotides was as high as 82%
[21,28].
It was reported that the level of PrP
C in the brain
represents less than 0.1% of the total amount of protein in
the central nervous system; moreover, in other tissues, this
concentration is much lower [2]. To detect the expression of
bovine prion protein in transfectant, immunoprecipitation
was applied using a combination of protein G-coupled
agarose and monoclonal antibody 6H4, which has a single
linear epitope, DYEDRYYRE, corresponding to positions
144-152 of bovine prion protein [18]. The endogenous
hamster prion protein was also detected by immuno-
precipitation because hamster PrP
C has a similar epitope,
differing only in that it has tyrosine at residue 145 rather
than the tryptophan of the bovine form [21,28]. The upper
band in the Western blot, which was observed only in
bovine Prnp-transfectant, seems to be exogenous, while the
lower band in CHO-K1 cells might also be endogenous.
PrP
C associating with lipid rafts via its GPI anchor has
been shown to be a component of the multi-molecular
signaling complex, although questions remain as to how the
GPI-anchored PrP
C, which is present on the extracellular
face of the plasma membrane, can directly interact with
signaling proteins on the cytosolic face [35]. 
When assessed by MTT and LDH assays, the bovine
Prnp-transfectant showed lower proliferation rates and
higher LDH release than the wild-type CHO-K1 cells,
which suggests that cell viability is decreased with co-
expression of both endo- and exogenous prion protein.
Although PrP
C in neuronal cells and lymphocytes play an
important role in increasing cell proliferation [32,34], CHO-
K1 cells transfected with bovine Prnp decreases rather than
increases. However, no morphological change was found
under microscopic observation.
The LPS-induced production of NO in neuronal cells
affected by prion disease has been studied because prions
and the major LPS receptor, CD14, are colocalized in lipid
rafts through a GPI anchor [20]. Previous research found
that, upon treatment with LPS, neuroblastoma N2a cells
respond with dose- and time-dependent NO production via
increased iNOS mRNA and protein expression. However, in
this study, bovine Prnp-transfectant co-expressing endogenous
and exogenous prion protein did not show detectable
production of NO with LPS or ConA stimulation, and
neither did wild-type CHO-K1 cells. This might be due to
the use of different types of cells. To induce NO production
in CHO-K1 cells, the activation of sphingomyelinase with
basic fibroblast growth factor was required to allow the
dissociation of the endothelial form of NO synthase from
caveolin 1 and its translocation to the cytosol, where it
catalyzes the synthesis of NO [10].
Prion protein may have a role in protecting against
oxidative stress, and this protection is mediated by Cu/Zn
SOD. This has been reported in recombinant, mutant, and
normal prion protein in vitro and in vivo [14,23,30,31]. It
may be a stress sensor that is sensitive to copper at
octapeptide repeats, and it is able to initiate a signal
transduction process acting on the antioxidant systems [29].
In addition, the level of the total SOD activity was correlated
Fig. 4. Analysis of apoptotic cell death. To induce apoptosis,
both CHO-K1 cells transfected with bovine Prnp (PrP) and wild-
type CHO-K1 (CHO) were treated with 200 µg/ml of
cyclohexamide and harvested at each time point (0, 3, 6, 9, 12
and 24 h). Panel A shows the result of DNA laddering assay.
Lane L: DNA ladder; Lanes 1 to 6: CHO-K1 cells transfecte d
with bovine Prnp, Lane 7 to 12 wild-type CHO-K1 cells. Panel B
is a results of caspase-3 activity assay calculated wit h
comparison to the pNA calibration curve. *p < 0.05 compared
with wild-type CHO-K1 cells.136 Sang-Gyun Kang et al.
to the level of prion protein expressed [37]. Our results
coincide with other reports that bovine Prnp-transfectant
expressing both endo- and exogenous prion protein showed
higher SOD activity when stimulated with ConA than do
wild-type CHO-K1 cells expressing only endogenous
protein. This suggests that the expression of the introduced
bovine Prnp aids in the cellular response of the donor CHO-
K1 cells to oxidative stress.
It has been reported that prion protein plays a neuroprotective
role against apoptosis induced by serum deprivation, and the
octapeptide repeat region of prion protein plays an essential
role in regulating apoptosis through the activation of SOD
and the inactivation of caspase-3/9 [9,16,31]. In our study on
apoptosis, caspase-3 activity in bovine Prnp-transfectant
lysate was higher than that in the wild-type at 24 h after
treatment with cyclohexamide, although it was difficult to
establish a visual difference in DNA fragmentation. This
indicates that the expression of exogenous bovine prion
protein enhanced cellular protection from apoptosis.
In the present study, we described the transfection of the
Prnp ORF from Korean cattle into CHO-K1 cells, and the
determination of the cellular changes according to different
parameters. These cellular changes indicated that the
viability of CHO-K1 cells were decreased by the expression
of exogenous bovine Prnp, but the cells showed higher
cellular protection against antioxidative stress and apoptosis.
However, to clarify whether these changes were entirely due
to the bovine Prnp or whether there was an additive effect
between bovine and hamster Prnp, further experimentation
using hamster Prnp
-/- and bovine Prnp
+/+ neuron cell lines
will be necessary. The reconstructed bovine Prnp-transfectant
stably expressing the gene might be considered as a
profitable tool for further BSE research.
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